Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

13.83
-0.3300-2.33%
Volume:1.42M
Turnover:19.70M
Market Cap:2.24B
PE:627.55
High:14.27
Open:14.12
Low:13.76
Close:14.16
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:1.18
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:9.29
PE(LYR):311.51

Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
39 mins ago

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.
·
5 hours ago

Vertex Pharmaceuticals resumed with an Overweight at Morgan Stanley

TIPRANKS
·
11 hours ago

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live
·
Yesterday

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

TIPRANKS
·
Yesterday

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

TIPRANKS
·
Yesterday

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

TIPRANKS
·
Yesterday

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.
·
Yesterday

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

TIPRANKS
·
Aug 29

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

TIPRANKS
·
Aug 29

Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026

TIPRANKS
·
Aug 27

Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.

TIPRANKS
·
Aug 27

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 27

Vertex Highlights Fy2025 Revenue of $748M in Investor Presentation on Intelligent Tax Compliance Platform

Reuters
·
Aug 27

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.
·
Aug 25

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.
·
Aug 24

Is Vertex Pharmaceuticals (VRTX) Cheap Following Its Raised 2026 Revenue Guidance?

Simply Wall St.
·
Aug 23

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial

TIPRANKS
·
Aug 21